ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.465,69
-0,03%
S&P 500
5.180,74
1,03%
US Dollar vs BRL
5,0765
0,00%
Bitcoin
64.112,09
1,50%
Brent Oil
82,91
-0,68%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Celsion Corporation (CLSN)

  7. Celsion Corporation (CLSN) Notícias

CLSN

Celsion (CLSN)

Celsion Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CLSN
DataHoraFonteTítuloCódigoCompanhia
15/06/202317:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLSNCelsion Corporation
11/05/202310:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CLSNCelsion Corporation
28/04/202317:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CLSNCelsion Corporation
28/04/202317:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CLSNCelsion Corporation
30/03/202309:22Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CLSNCelsion Corporation
21/03/202317:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLSNCelsion Corporation
03/10/202218:19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLSNCelsion Corporation
19/09/202217:30GlobeNewswire Inc.Celsion Corporation Announces Company Name Change to Imunon, Inc.NASDAQ:CLSNCelsion Corporation
15/09/202212:55TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Celsion (CLSN)NASDAQ:CLSNCelsion Corporation
15/09/202209:30GlobeNewswire Inc.Celsion Completes Enrollment of the Phase I/II OVATION 2 Study with GEN-1 in Advanced Ovarian CancerNASDAQ:CLSNCelsion Corporation
12/09/202219:30GlobeNewswire Inc.Celsion Corporation Presentation Time at the H.C. Wainwright 24th Annual Global Investment Conference Changed to 4:30 p.m. ET on September 13NASDAQ:CLSNCelsion Corporation
07/09/202210:15GlobeNewswire Inc.Celsion Corporation to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:CLSNCelsion Corporation
01/09/202213:15TipRanksH.C. Wainwright Keeps Their Buy Rating on Celsion (CLSN)NASDAQ:CLSNCelsion Corporation
01/09/202209:30GlobeNewswire Inc.Celsion Corporation Highlights Progress in its DNA-based Vaccine ProgramNASDAQ:CLSNCelsion Corporation
15/08/202219:00Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLSNCelsion Corporation
08/08/202209:30GlobeNewswire Inc.Celsion Corporation to Hold Second Quarter 2022 Financial Results and Business Update Conference Call on Monday, August 15, 2022NASDAQ:CLSNCelsion Corporation
19/07/202209:35GlobeNewswire Inc.Celsion Corporation Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)NASDAQ:CLSNCelsion Corporation
19/07/202209:30GlobeNewswire Inc.Celsion Appoints Dr. Corinne Le Goff as President and Chief Executive OfficerNASDAQ:CLSNCelsion Corporation
26/06/202209:25TipRanksDawson James Sticks to Their Hold Rating for Celsion (CLSN)NASDAQ:CLSNCelsion Corporation
24/06/202209:35GlobeNewswire Inc.Life Sciences Investor Forum Presentations Now Available for On-Demand ViewingNASDAQ:CLSNCelsion Corporation
21/06/202209:30GlobeNewswire Inc.Celsion Reports Data Safety Monitoring Board Unanimous Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian CancerNASDAQ:CLSNCelsion Corporation
17/05/202207:15TipRanksAnalysts Offer Insights on Healthcare Companies: Celsion (CLSN), Altimmune (ALT) and Albireo Pharma (ALBO)NASDAQ:CLSNCelsion Corporation
10/05/202209:30GlobeNewswire Inc.Celsion Corporation Highlights Pipeline Progress in Its Lead Development CandidatesNASDAQ:CLSNCelsion Corporation
09/05/202209:30GlobeNewswire Inc.Celsion Corporation to Hold First Quarter 2022 Financial Results and Business Update Conference Call on Monday, May 16, 2022NASDAQ:CLSNCelsion Corporation
21/04/202212:30GlobeNewswire Inc.Celsion Corporation Highlighted its PLACCINE Vaccine Platform Technology During Oral Presentation at the World Vaccine CongressNASDAQ:CLSNCelsion Corporation
14/04/202209:30GlobeNewswire Inc.Celsion and Medidata Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial at 2022 AACR Annual MeetingNASDAQ:CLSNCelsion Corporation
13/04/202207:15TipRanksAnalysts’ Top Healthcare Picks: Celsion (CLSN), Acer Therapeutics (ACER)NASDAQ:CLSNCelsion Corporation
12/04/202209:30GlobeNewswire Inc.Celsion Corporation to Highlight its PLACCINE Platform Technology During Oral Presentation at the World Vaccine CongressNASDAQ:CLSNCelsion Corporation
08/04/202217:30GlobeNewswire Inc.Celsion Corporation Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:CLSNCelsion Corporation
08/04/202207:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CLSNCelsion Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:CLSN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
MNPR3
MINUPAR ON
BOV
ENAT3
ENAUTA ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
PRIO3
PETRORIO ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
TELB4
TELEBRAS PN
BOV
HOOT4
HOTEIS OTHON PN
BOV
COGN3
COGNA ON
BOV
GOLL4
GOL PN
BOV
LIGT3
LIGHT ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados